[Code of Federal Regulations] |
[Title 21, Volume 5] |
[Revised as of April 1, 2020] |
[CITE: 21CFR358.701] |
|
|
CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES |
|
SUBCHAPTER D - DRUGS FOR HUMAN USE |
|
PART 358 -- MISCELLANEOUS EXTERNAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE
Subpart H - Drug Products for the Control of Dandruff, Seborrheic Dermatitis, and Psoriasis
(a) An over-the-counter dandruff, seborrheic dermatitis, or psoriasis drug product in a form suitable for topical application is generally recognized as safe and effective and is not misbranded if it meets each of the conditions in this subpart and each general condition established in § 330.1 of this chapter.
(b) References in this subpart to regulatory sections of the Code of Federal Regulations are to chapter I of title 21 unless otherwise noted.
|
|